405 results on '"Cheng, Guang‐Shing"'
Search Results
52. Acute Pulmonary Complications of Bone Marrow and Stem Cell Transplantation
53. Contributors
54. Pneumomediastinum and Mediastinitis
55. Mediastinal Tumors and Cysts
56. 125 - Pulmonary Complications of Stem Cell and Solid Organ Transplantation
57. 115 - Mediastinal Tumors and Cysts
58. In Practice: Peace
59. The paradox of immunosuppressants and COVID-19
60. Infectious Complications after Intensive Chemotherapy with CLAG-M or '7+3' for Adults with Acute Myeloid Leukemia and Other High-Grade Myeloid Neoplasms
61. 923. Respiratory Syncytial and Parainfluenza Virus Infection Increase the Risk of Cytomegalovirus Reactivation in Allogeneic Hematopoietic Cell Transplant Recipients
62. Decision letter: Investigating phenotypes of pulmonary COVID-19 recovery: A longitudinal observational prospective multicenter trial
63. A Phase II Multicenter Trial of Ruxolitinib to Treat Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplantation
64. Progressive Pulmonary Infiltrates in a Man with Mediastinal Lymphoma
65. Clinical and Virologic Characteristics and Outcomes of Coronavirus Disease 2019 at a Cancer Center
66. Pulmonary Complications of Pediatric Hematopoietic Cell Transplantation. A National Institutes of Health Workshop Summary
67. Immune Correlates from a Prospective Trial Suggest Leukotriene Signaling and Alternative Macrophage Activation in Clinical Bronchiolitis Obliterans Syndrome
68. Which Respiratory Virus Infections Are Associated with Increased Risk of Specific Bacterial Infection in Allogeneic Hematopoietic Cell Transplant Recipients?
69. To Toci or Not to Toci for COVID-19: Is That Still the Question?
70. Multicenter evaluation of parametric response mapping as an indicator of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation
71. Prospective Phase Ii Trial of Montelukast to Treat Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation and Investigation into Bos Pathogenesis
72. 427 - Supplemental Oxygen-Free Days in Human Rhinovirus Infections of the Lower Respiratory Tract in Hematopoietic Cell Transplant Recipients
73. 129 - Bronchiolitis Obliterans Syndrome in Myelofibrosis Patients Post-Allogeneic Hematopoietic Cell Transplantation
74. Colaboradores
75. Pharmacologic Activation of the Innate Immune System to Prevent Respiratory Viral Infections
76. Tocilizumab in hospitalized patients with COVID‐19: Clinical outcomes, inflammatory marker kinetics, and safety
77. Feasibility and Reliability of Home-based Spirometry Telemonitoring in Allogeneic Hematopoietic Cell Transplant Recipients
78. Feasibility of home spirometry in patients with chronic graft-versus-host disease: a prospective observational study
79. Tocilizumab in hospitalized patients with COVID-19: Clinical outcomes, inflammatory marker kinetics, safety, and a review of the literature
80. To Toci or Not to Toci for Coronavirus Disease 2019 (COVID-19): Is That Still the Question?
81. The novel coronavirus disease (COVID‐19) complicated by pulmonary embolism and acute respiratory distress syndrome
82. Survival, Nonrelapse Mortality, and Relapse-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: Comparing 2003–2007 Versus 2013–2017 Cohorts
83. Diagnosis of pulmonary hypertension by noninvasive methods in hematopoietic cell transplant patients with myelofibrosis
84. A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant Recipients
85. Acute hypoxaemic respiratory failure in immunocompromised patients: abandon bronchoscopy or make it better?
86. Role of alveolar epithelial early growth response-1 (Egr-1) in CD8+ T cell-mediated lung injury
87. Contributors
88. Predictive Value of Respiratory Viral Detection in the Upper Respiratory Tract for Infection of the Lower Respiratory Tract With Hematopoietic Stem Cell Transplantation
89. Herpesviruses: Silent Instigators of Lung Injury after Hematopoietic Cell Transplant
90. Early Respiratory Viral Acquisition after Allogeneic Hematopoietic Cell Transplant (HCT)
91. Human Metapneumovirus or Influenza A Upper Respiratory Tract Infection Associated with Increased Risk of Bacterial Superinfection in Allogeneic Hematopoietic Cell Transplant Recipients
92. Tocilizumab in hospitalized patients with COVID‐19: Clinical outcomes, inflammatory marker kinetics, and safety.
93. 84 - Pneumomediastino e mediastinite
94. 83 - Tumores e cistos mediastinais
95. A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant Recipients.
96. 89 - Which Respiratory Virus Infections Are Associated with Increased Risk of Specific Bacterial Infection in Allogeneic Hematopoietic Cell Transplant Recipients?
97. 85 - Immune Correlates from a Prospective Trial Suggest Leukotriene Signaling and Alternative Macrophage Activation in Clinical Bronchiolitis Obliterans Syndrome
98. Predictive Value of Respiratory Viral Detection in the Upper Respiratory Tract for Infection of the Lower Respiratory Tract With Hematopoietic Stem Cell Transplantation.
99. Disability related to chronic graft -versus-host disease after alternative donor hematopoietic cell transplantation
100. 750. Respiratory Virus Infections and Airflow Obstruction After Allogeneic Hematopoietic Cell Transplantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.